In New SELECT Trial Analysis, Early Reduction in Cardiovascular Events Was Observed with Wegovy®, Before Clinically Meaningful Changes in Body Weight
PLAINSBORO, N.J., May 13, 2025 /PRNewswire/ -- Today, Novo Nordisk will present data at the European Congress of Obesity (ECO) from a secondary, post hoc analysis of the SELECT trial that showed within the first three months of treatment, reductions...
PLAINSBORO, N.J., May 13, 2025 /PRNewswire/ -- Today, Novo Nordisk will present data at the European Congress of Obesity (ECO) from a secondary, post hoc analysis of the SELECT trial that showed within the first three months of treatment, reductions...
.jpeg)
